Author / Subject Indexes
John M. Goldman(UPMC Central Pa), P. Celérier(Centre Hospitalier de La Rochelle), Alan York(The University of Melbourne), Catherine Lindgren(Unknown), Christopher Arthur(Royal North Shore Hospital), C M Massumoto, P Litoux(Nantes Université), Brigitte Dreno, A. Fefer, Jack W. Singer(NorthShore University HealthSystem), Carl M. Higuchi, Wendy H. Raskind(Pacific Northwest Diabetes Research Institute), JA. Thompson, Dávid Ma(St Vincent's Hospital Sydney), Pierre Fenaux(Université Paris Cité), CD Buckner(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Celestia S. Higano(University of British Columbia), Mark Benyunes(Roche (Switzerland))
Cited by 0
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k